Clinical Trial

Remimazolam vs Propofol in Laser Burn Cases

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This randomized, single-blind, crossover study compares remimazolam and propofol for monitored anesthetic care during fractional ablative CO₂ laser therapy for burn scars. The primary aim is to assess incidence of respiratory depression, defined as a need for advanced airway maneuvers (jaw thrust/chin lift, insertion of oral or nasal airway, or bag mask ventilation), and hypopnea (respiratory rate \< 8).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-01.
Status change: Not Yet Recruiting → Recruiting 2025-11-17
Trial Details
NCT Number NCT07213544
Lead Sponsor Medical University of South Carolina
Conditions Burn Scar, Hypertrophic Scarring, Procedural Sedation
Enrollment 136 participants
Start Date 2025-11-12
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-11-20